Skip to main content
OpenTrials
Completed

NCT Number: NCT05061173

Comparison of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults

To compare the effects of aerobic, resistance and combined training in hypertensive obese patients

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

District Headquarter Hospital - kotli

Kotli, Azad Jamu Kashmir, 11100, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hypertensive with BP greater than 140/90 mmHg
  • Overweight and obese adults with BMI (25-40)
  • Physically inactive from past 6 months assessed with pedometer. Those with step count of less than 7000 will be included
  • To be able to exercise (6MWT),t hose who completed the test without any symptom

Exclusion criteria

  • Any active systemic illness that restricts exercise
  • People doing exercise on regular basis
  • Any cardiopulmonary , metabolic and neurological illness

Treatment and study plan

Aerobic exercise training Group

Other

Aerobic Exercise includes Treadmill walking At Week 1-2, intensity of 40-45% Heart rate maximum (HR max), 3 days/week, for 30 minutes At Week 3-4, intensity of 45-50% HR max, 3 days /week, for 30 minutes At Week 5-6, intensity of 50-60% HR max 3 days per week, for 30 minutes

Resistance Exercise Training Group

Other

Resistive Exercises includes (a) Leg press b) Quadriceps extension c) Bicep curl d) Hip abduction.

At Week 1-2, 10 repetitions 1 set, 3 days/week, for 30 minutes At Week 3-4, 2 sets of 10 repetitions, 3 times /week for 30 minutes At week 5-6, 2 sets of 10 repetitions with 5 sec hold 3 times per week for 30 minutes

Combined Exercise Training Group

Other

Combined Exercise training includes [Aerobic: Treadmill walking + Resistive Training: a) Leg press b) Quadriceps extension c) Bicep curl d) Hip abduction] Time will be reduced to 15 minutes for both trainings in respective weeks. Aerobic Exercise includes Treadmill walking At Week 1-2, intensity of 40-45% Heart rate maximum (HR max), 3 days/week, for 15 minutes At Week 3-4, intensity of 45-50% HR max, 3 days /week, for 15 minutes At Week 5-6, intensity of 50-60% HR max 3 days per week, for 15 minutes

Resistive Exercises At Week 1-2, 10 repetitions 1 set, 3 days/week, for 15 minutes At Week 3-4, 2 sets of 10 repetitions, 3 times /week for 15 minutes At week 5-6, 2 sets of 10 repetitions with 5 sec hold 3 times per week for 15 minutes

Primary outcomes

  1. Systolic and diastolic blood pressure

    Time frame: 6 weeks

    Changes from the Baseline, Blood pressure is measured through sphygmomanometer

  2. Body Mass Index (BMI)

    Time frame: 6 Week

    Changes from the Baseline, Body mass index (BMI) will be calculated as weight (kg)/height (m2). Below 18.5 Underweight 18.5 - 24.9 Healthy Weight 25.0 - 29.9 Overweight 30.0 and Above Obesity

  3. Change in blood lipid profile

    Time frame: 6 Week

    Change in plasma total cholesterol, high density lipoproteins cholesterol (HDL), and low density lipoproteins cholesterol (LDL) after each treatment.

  4. Step Count

    Time frame: 6 week

    Pedometer is a valid self-report measure of physical activity. Pedometer is used to count the average daily steps. Change from the baseline to 6 week will be compared.

  5. Waist circumference

    Time frame: 6 week

    Waist circumference will be measured for abdominal or central fat mass. It is measured in cm at the middle distance between the last floating rib and the iliac crest using a retractable ergonomic measuring tape. Change from the baseline to 6 week will be compared.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Compare the Effects of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Sep 29, 2021
Registry last updated
Oct 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.